Clinical guidelines for management

被引:8
作者
Scott, DL
机构
[1] Clinical and Academic Rheumatology, King's College Hospital, London SE22 8PT, East Dulwich Grove
来源
BAILLIERES CLINICAL RHEUMATOLOGY | 1997年 / 11卷 / 01期
关键词
rheumatoid arthritis; clinical guidelines; disease management;
D O I
10.1016/S0950-3579(97)80039-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Guidelines provide explicit recommendations and seek to influence practice using a formal process to disseminate advice on most effective management in the light of scientific evidence. They provide a framework for the evaluation and treatment of common clinical problems, but are not intended to replace clinical judgement. There is considerable variation in rheumatology practice, fuelled by uncertainty about the optimal measurement of disease outcome. Guidelines can help identify and eliminate ineffective or unnecessary care as they are systematically developed statements to assist practitioners and patients' decisions about appropriate health care. There are North American guidelines for: the initial evaluation of adult patients with acute musculoskeletal symptoms, the management of rheumatoid arthritis and the management of osteoarthritis. These are discussed together with proposed guidelines for the management of early rheumatoid arthritis and areas of research into the value of guidelines. It is recommended that future work in this area should: (i) identify aspects of current guidelines which are directly related to outcome; (ii) educate clinicians in these aspects of care; (iii) ensure they are introduced into practice and the outcome of care subsequently Improves; (iv) regularly update the guidelines to reflect current opinion. Present guidelines that give broadly similar recommendations from North American and UK perspectives. However, the available evidence all points to large variations between how clinicians practise and how they make their decisions and it may be unlikely that laying down exact recipes for practice will necessarily influence the clinician. Guidelines may appear relevant but they could prove to have very limited utility.
引用
收藏
页码:157 / 179
页数:23
相关论文
共 78 条
[11]   2ND LINE (DISEASE-MODIFYING) TREATMENT IN RHEUMATOID-ARTHRITIS - WHICH DRUG FOR WHICH PATIENT [J].
CAPELL, HA ;
PORTER, DR ;
MADHOK, R ;
HUNTER, JA .
ANNALS OF THE RHEUMATIC DISEASES, 1993, 52 (06) :423-428
[12]  
Capell HA, 1995, BRIT J RHEUMATOL, V34, P35
[13]  
COMER M, 1994, BRIT J RHEUMATOLO S1, V33, P139
[14]  
CUSHNAGHAN J, 1988, BRIT MED J, V308, P753
[16]   INTRA-ARTICULAR STEROIDS IN OSTEO-ARTHRITIS [J].
DIEPPE, PA ;
SATHAPATAYAVONGS, B ;
JONES, HE ;
BACON, PA ;
RING, EFJ .
RHEUMATOLOGY AND REHABILITATION, 1980, 19 (04) :212-217
[17]  
EDMONDS JP, 1993, J RHEUMATOL, V20, P585
[18]   ANTIRHEUMATIC DRUGS - A PROPOSED NEW CLASSIFICATION [J].
EDMONDS, JP ;
SCOTT, DL ;
FURST, DE ;
BROOKS, P ;
PAULUS, HE .
ARTHRITIS AND RHEUMATISM, 1993, 36 (03) :336-339
[19]   OBESITY AND KNEE OSTEO-ARTHRITIS - THE FRAMINGHAM-STUDY [J].
FELSON, DT ;
ANDERSON, JJ ;
NAIMARK, A ;
WALKER, AM ;
MEENAN, RF .
ANNALS OF INTERNAL MEDICINE, 1988, 109 (01) :18-24
[20]   WEIGHT-LOSS REDUCES THE RISK FOR SYMPTOMATIC KNEE OSTEOARTHRITIS IN WOMEN - THE FRAMINGHAM-STUDY [J].
FELSON, DT ;
ZHANG, YQ ;
ANTHONY, JM ;
NAIMARK, A ;
ANDERSON, JJ .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (07) :535-539